Bhavna Gami,Faris Kubba,Paul Ziprin
Bhavna Gami
The incidence of anal cancer is increasing. In the UK, the incidence is estimated at approximately 1.5 per 100,000. Most of this increase is attributed to certain at-risk populations. Persons who are human immunodeficiency virus (HIV)-posit...
Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information [0.03%]
Ki-67、肿瘤大小和孕酮受体阴性差异的腔面型A与B亚型的预后信息
Zorka Inic,Milan Zegarac,Momcilo Inic et al.
Zorka Inic et al.
Background: The St. Gallen International Expert Consensus of 2011 proposes a new classification system for breast cancer based on its division into five subgroups. The criteria to identify these subtypes were recently ref...
Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant-A Prospective Phase II Study [0.03%]
根据多发性骨髓瘤患者对首次移植反应进行自体干细胞移植的临床II期研究
Michael Byrne,Donya Salmasinia,Helen Leather et al.
Michael Byrne et al.
In this prospective phase II clinical trial, multiple myeloma (MM) patients were randomized to receive a second (tandem) autologous stem cell transplantation (ASCT) based on whether they achieved a partial response or worse (≤PR) following...
Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia [0.03%]
儿童及青少年急性淋巴细胞白血病患者中L-天冬酰胺酶应用的更新意见
Augusto F Andrade,Kleiton S Borges,Vanessa S Silveira
Augusto F Andrade
Great improvements have been made in acute lymphoblastic leukemia (ALL) treatment in the past decades, especially due to the use of l-asparaginase (l-ASP). Despite the significant success rate, several side effects mainly caused by toxicity...
Case Report About Fatal or Near-Fatal Hypersensitivity Reactions to Cetuximab: Anticetuximab IgE as a Valuable Screening Test [0.03%]
关于西妥昔单抗致死性或近致死性过敏反应的病例报告：抗西妥昔单抗IgE检测作为筛查试验的价值
Benoît Dupont,Delphine Mariotte,Cristian Moldovan et al.
Benoît Dupont et al.
Hypersensitivity reactions are a classic side effect of cetuximab. We report the cases of three patients who developed life-threatening hypersensitivity to cetuximab, which could have been predicted by assessing the concentration of serum a...
Advanced Extramammary Paget's Disease of the Groin, Penis, and Scrotum [0.03%]
高级外阴Paget病的腹股沟、阴茎和阴囊病变
Derek Isrow,Karlos Z Oregel,Javier Cortes et al.
Derek Isrow et al.
Extramammary Paget's disease (EMPD) is a rare intraepithelial malignancy arising in areas rich in apocrine glands, such as the perineum, vulva, axilla, scrotum, and penis. We describe the case of a man in his 50s who initially presented wit...
The Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Oropharyngeal Carcinoma Treated with Chemoradiotherapy [0.03%]
接受同期放化疗的口腔咽癌患者中粒细胞与淋巴细胞比值的预后价值分析
Caroline A Young,Louise J Murray,Ebru Karakaya et al.
Caroline A Young et al.
Background: The aim of the study is to investigate the prognostic role of pre-treatment of markers of the systemic inflammatory response (neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and album...
Narjiss Berrada,Siham Lkhoyali,Hind Mrabti et al.
Narjiss Berrada et al.
Although basal cell carcinoma (BCC) is the most common cancer worldwide, its metastatic dissemination is exceptional. Before 2012, we had a few treatment options available for metastatic or locally advanced cases. Management of these patien...
Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics [0.03%]
肝细胞癌诊断和治疗的新趋势
Avegail Flores,Jorge A Marrero
Avegail Flores
Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide and one of the deadliest. Patients with chronic liver disease are at the highest risk for developing this tumor. This link provides an opportunity for developing prev...
Oncology nursing support for safe and effective use of eribulin in metastatic breast cancer [0.03%]
关于厄洛替尼用于转移性乳腺癌护理的安全及有效性的肿瘤科护士支持研究
Diana Donovan,Laura Urquhart,Una Hopkins et al.
Diana Donovan et al.
Nurse practitioners play important roles in breast cancer prevention, early detection, therapeutic efficacy, and surveillance. Assessment of a patient's health status is part of the nine nurse practitioner core competencies updated in 2012 ...